ALLR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Allarity Therapeutics Inc (ALLR) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak technical indicators, poor financial performance, and lacks positive catalysts or strong trading signals. Given the investor's profile and the lack of compelling reasons to invest, it is recommended to avoid this stock.
The technical indicators for ALLR are bearish. The MACD is negative and expanding downward, the RSI is neutral but leaning towards oversold territory, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 1.067, with resistance at 1.191. Overall, the technical outlook suggests further downside risk.
NULL identified. There is no recent news, no positive trading trends from hedge funds or insiders, and no significant events or catalysts driving the stock upward.
is also down (-1.79%). Additionally, there is no congress trading data or influential figure activity to support the stock.
In Q3 2025, the company's revenue remained at 0, showing no growth. Net income dropped to -$2,806,000, down -76.91% YoY, and EPS fell to -$0.19, down -97.54% YoY. Gross margin remained at 0, indicating no profitability. The financials reflect a struggling company with no signs of improvement.
No analyst rating or price target changes were provided. There is no indication of Wall Street sentiment towards the stock.
